Muñoz M Alma, Abarca V Katia, Jiménez de la J Jorge, Luchslnger F Vivían, O'Ryan G Miguel, Ripoll M Erna, Valenzuela B M Teresa, Vergara F Rodrigo
Rev Chilena Infectol. 2007 Oct;24(5):372-6. doi: 10.4067/s0716-10182007000500004. Epub 2007 Oct 26.
Thimerosal is a mercury derivative included in vaccines since 1930 with the aim to prevent microbial contamination. During the last decades, the use of thimerosal has been questioned, specifically because of a potential association with neurotoxicity. After a thorough review of published studies on pediatric use of thimerosal-containing vaccines, and of position papers from international expert groups, the Consultive Committee of Immunizations of the Chilean Society of Infectious Diseases concludes that there is no solid evidence of adverse events associated with the use of thimerosal containing vaccines in infants and children. Therefore, a change in current vaccine practices refererred to thimerosal-containing vaccines is not justified in Chile.
硫柳汞是一种汞衍生物，自1930年起被用于疫苗中，目的是防止微生物污染。在过去几十年里，硫柳汞的使用受到了质疑，特别是因为它可能与神经毒性有关。在对已发表的关于含硫柳汞疫苗在儿科使用的研究以及国际专家组的立场文件进行全面审查后，智利传染病学会免疫咨询委员会得出结论，没有确凿证据表明婴儿和儿童使用含硫柳汞疫苗会出现不良事件。因此，在智利，改变目前针对含硫柳汞疫苗的疫苗接种做法是不合理的。
